Certain heterozygous variants in the kinase domain of the serine/threonine kinase NEK8 can cause an autosomal dominant form of polycystic kidney disease

Laura R. Claus(University Medical Center Utrecht), F. Maleady-Crowe(Genomics England), Nathalie Demoulin, Tim Hubbard(King's College London), L. Lahnstein(University of Cambridge), Eiske M. Dorresteijn(Erasmus MC), Melis Kayikci(Jackson Laboratory), Holly Mabillard(Newcastle upon Tyne Hospitals NHS Foundation Trust), Tjakko J. van Ham(Erasmus MC), Karin Dahan(Cliniques Universitaires Saint-Luc), C. R. Boustred(Jackson Laboratory), Greg Elgar(Genomics England), Sarah R. Senum(Mayo Clinic), Jordan Lerner‐Ellis(Ontario Institute for Cancer Research), I. U. S. Leong(Genomics England), Gisela G. Slaats(University of Cologne), Alexandra L. Hawks(Clemson University), Tahsin Stefan Barakat(Erasmus University Rotterdam), Athanasios Kousathanas(Jackson Laboratory), Chantal F. Morel(MACOM (United States)), Dalia Kasperavičiūtė(University of Leeds), Adam Giess(Jackson Laboratory), Marta Bleda(University of Cambridge), Raymond J. Louie(Greenwood Genetic Center), Joshua L. Turner(Clemson University), Prabhu Arumugam(Jackson Laboratory), Tom Fowler(UK Health Security Agency), Marjon van Slegtenhorst(Erasmus MC), Helen Brittain(Great Ormond Street Hospital), S. E. A. Leigh(Queen Mary University of London), Angela Hamblin(Genomics England), Eric Olinger(Cliniques Universitaires Saint-Luc), G. C. Chan(Jackson Laboratory), Mark J. Caulfield(Queen Mary University of London), Robert B. Jackson(Cardiovascular Institute of the South), Frank Sleutels(Erasmus MC), Jennifer L. Stallworth(Greenwood Genetic Center), Chloe Mighton(McMaster University), Heather Flanagan‐Steet(Greenwood Genetic Center), John C. Ambrose(Jackson Laboratory), Chuan Chen(Mayo Clinic), Louise J. Jones, Alice S. Brooks(Erasmus MC), Sujata Srikanth(Greenwood Genetic Center), Javier F. Lopez, Éric Goffin(Cliniques Universitaires Saint-Luc), Josh Silver(MACOM (United States)), R. Bevers(Maastricht University)
Kidney International
August 18, 2023
10.1016/j.kint.2023.07.021
Cited by 38

Related Papers

GENCODE: The reference human genome annotation for The ENCODE Project
|Genome Research|2012|5k
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
|The Lancet|2003|3.8k
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
|The Lancet|2005|2.9k
The Global Methane Budget 2000-2017
|NOAA Institutional Repository|2019|2.6k
Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people
|The Lancet|2014|1.6k